You searched for metabolic diseases - Page 36 of 62

In Depth 22 Jul 2022

The coming of age story of RNAi technology

…levels and another for rare hematological diseases like beta-thalassemia and myelodysplastic syndrome. The former silences the LPA gene, lowering lipoprotein(a) levels and reducing the risk of heart diseases and strokes….

July 22, 2022 - 7 minutesmins - By Farhan Mitha

Podcast 2 Feb 2024

BioSenic showcasing knee osteoarthritis treatment

…interesting, powerful drug that could be really revolutionary,” Nicco said. “I think that this compound could be incredibly useful for patients with really difficult diseases, autoimmune diseases, and we should…

February 2, 2024 - 7 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

…research started out exploring DNA damage pathways activated following nerve injury. However, the same molecular factors feature in pathways are seen in neurodegenerative diseases, and a full understanding of these…

September 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 18 Oct 2022

EditForce creates U-to-C RNA-editing technology

…or RNA sequence cause a variety of diseases. Treatment of these diseases requires single base-editing technology of repairing genomic or RNA mutations to bring the sequences back on the normal…

October 18, 2022 - 2 minutesmins - By Jim Cornall

arthritis pediatric juvenile idiopathic Leuven

News and Trends 13 Mar 2019

Artificial Intelligence Detects Juvenile Arthritis in the Blood

…unpick complex inflammatory diseases in other ways. One way is screening the genome for particular genes linked to these inflammatory diseases, and another is characterizing gut bacteria in the human…

March 13, 2019 - 3 minutesmins - By Jonathan Smith

epigenetics review cambridge epigenetix oryzon1

In Depth 5 Sep 2017

The Next Generation of Genetic Medicine: A Review of Epigenetics

…diseases, but their use as a monotherapy has not been satisfactory.” The efficacy of these drugs has been marred by individual sensitivities to them that are difficult to untangle such…

September 5, 2017 - 9 minutesmins - By Evelyn Warner

Altheia Science gene therapy autoimmune disease

News and Trends 19 Dec 2018

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

Altheia Science, based in Milan, has raised €17M to fund the development of gene therapies for autoimmune diseases with the remarkable potential to be curative. “The success of our fundraising…

December 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 May 2023

Cell and gene therapy company NewBiologix exits stealth with $50M

…experience in biotech and cell line development to the new entity. “Our mission is to help biopharmaceutical companies treat some of the most devastating diseases by providing them with innovative…

May 12, 2023 - 3 minutesmins - By Jim Cornall

In Depth 15 May 2019

The Missing Piece in the Microbiome Field

…beyond just cancer immunotherapy to many other diseases, and potentially even to neurodegenerative diseases, which also have an inflammatory component.” The intersection of cancer and the microbiome has attracted multiple…

May 15, 2019 - 7 minutesmins - By Clara Rodríguez Fernández

cognitive disorders syndesi therapeutics 1

News and Trends 1 Feb 2018

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Syndesi Therapeutics has been formed by UCB and a group of investors, including Novo Seeds and V-Bio to develop a group of compounds for cognitive disorders caused by diseases like…

February 1, 2018 - 3 minutesmins - By Alex Dale

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

…its potential to treat all sorts of diseases where the immune system is involved, including cancer and neurodegenerative conditions. As autoimmune diseases are directly caused by the immune system, immunotherapies…

March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Aug 2021

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

…therapies for a range of conditions, including respiratory, liver, and infectious diseases. The company’s €2.7B ($3.2B) buyout, announced by Sanofi earlier this month, seems a tacit acknowledgment of the potential…

August 17, 2021 - 5 minutesmins - By Mark Zipkin

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

The coming of age story of RNAi technology

BioSenic showcasing knee osteoarthritis treatment

Research identifies new treatment target for CNS injury and neurological disease

EditForce creates U-to-C RNA-editing technology

Artificial Intelligence Detects Juvenile Arthritis in the Blood

The Next Generation of Genetic Medicine: A Review of Epigenetics

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

Cell and gene therapy company NewBiologix exits stealth with $50M

The Missing Piece in the Microbiome Field

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!